Skip to main content

Table 1 Main demographic, clinical and treatment characteristics.

From: Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study

  

Evaluable Patients (N = 135)

No Evaluable Patients (N = 69)

Age (years)

Mean (SD)

66.6(12.4)

65.6(11.1)

Gender

Male

90 (66.7 %)

45(65.2 %)

Female

45 (33.3 %)

24(34.8 %)

Primary cancer site

Lung

42 (31.1 %)

21(30.4 %)

Prostate

27 (20.0 %)

10(14.5 %)

Breast

19 (14.1 %)

5(7.3 %)

Others

47 (34.8 %)

33(47.8 %)

Worst paina

Median (range)

8 (0–10)

8 (0–10)

RT dose

5 x 400 cGy

83 (61.5 %)

40(58.0 %)

1 x 800 cGy

42 (31.1 %)

20(29.0 %)

Other

10 (7.4 %)

9(13.0 %)

RT site

Pelvis

57 (42.2 %)

21(32.8 %)

Spine

39 (28.9 %)

25(39.1 %)

Extremities

20 (14.8 %)

11(17.2 %)

Others

19 (14.1 %)

7(10.9 %)

Bisphosphonates

YES

36 (26.7 %)

16(23.2 %)

NO

99 (73.3 %)

53(76.8 %)

Dexamethasone

YES

41 (30.8 %)

17(26.6 %)

NO

92 (69.2 %)

47(73.4 %)

  1. Abbreviations: RT = radiotherapy
  2. aWorst pain recorded using the Brief Pain Inventory (BPI): ranged from 0–10
Back to article page

BMC Palliative Care

ISSN: 1472-684X

Contact us